Literature DB >> 15554393

A BALB/c murine lung alveolar carcinoma used to establish a surgical spontaneous metastasis model.

Michael McLean1, Howard L Wallace, Atima Sharma, Hank C Hill, Michael S Sabel, Nejat K Egilmez.   

Abstract

Line-1, a weakly immunogenic lung tumor cell line derived from the BALB/c mouse, metastasizes spontaneously to the lungs of mice following subcutaneous administration. The parameters that influence metastasis as well as the progression of metastatic lung disease following surgical resection of primary subcutaneous tumors were characterized. Histological analysis of the lungs obtained from mice bearing different size subcutaneous tumors demonstrated that >90% of the mice developed micrometastatic disease in the lungs when the tumor exceeded 650 mm3 in size. Surgical resection of subcutaneous tumors resulted in the cure of primary disease in 95% of the mice. Macroscopic tumor nodules were grossly visible in the lungs of 75% of the mice 5 weeks after surgery. Serum amyloid A level correlated with primary tumor burden and was diagnostic for the presence of metastatic disease. The efficiency of metastasis, post-surgical primary tumor recurrence and long-term survival were significantly different between BALB/c mice obtained from different suppliers. The Line-1-BALB/c surgical metastasis model provides a clinically relevant tool for the evaluation of anti-cancer therapies, especially those that are designed to target long-term suppression of minimal residual disease following surgical intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15554393     DOI: 10.1023/b:clin.0000046176.33867.c5

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  23 in total

1.  C57BLack/BOX? The importance of exact mouse strain nomenclature.

Authors:  Carsten T Wotjak
Journal:  Trends Genet       Date:  2003-04       Impact factor: 11.639

2.  Inhibition of subcutaneously growing line 1 carcinomas due to metastatic spread.

Authors:  J M Yuhas; N H Pazmiño
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

3.  Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma.

Authors:  M Kimura; Y Tomita; T Imai; T Saito; A Katagiri; Y Ohara-Mikami; T Matsudo; K Takahashi
Journal:  Cancer       Date:  2001-10-15       Impact factor: 6.860

4.  Neoadjuvant immunotherapy with interferon of the spontaneously metastasizing murine B16F10L melanoma.

Authors:  S N Markovic; D M Murasko
Journal:  Int J Cancer       Date:  1990-04-15       Impact factor: 7.396

5.  Serum amyloid A protein (SAA) in colorectal carcinoma.

Authors:  I Glojnarić; M T Casl; D Simić; J Lukac
Journal:  Clin Chem Lab Med       Date:  2001-02       Impact factor: 3.694

6.  B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma.

Authors:  K Y Yeh; B A Pulaski; M L Woods; A J McAdam; A A Gaspari; J G Frelinger; E M Lord
Journal:  Cell Immunol       Date:  1995-10-15       Impact factor: 4.868

7.  Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.

Authors:  Hank C Hill; Thomas F Conway; Michael S Sabel; Yong S Jong; Edith Mathiowitz; Richard B Bankert; Nejat K Egilmez
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

8.  Synergistic effects of co-expression of the TH1 cytokines IL-2 and IFN-gamma on generation of murine tumor-reactive cytotoxic cells.

Authors:  A J McAdam; B A Pulaski; S S Harkins; E K Hutter; E M Lord; J G Frelinger
Journal:  Int J Cancer       Date:  1995-05-29       Impact factor: 7.396

9.  Enhanced immune recognition of H-2 antigen-deficient murine lung carcinoma cells following treatment with dimethyl sulfoxide.

Authors:  D W Bahler; E M Lord
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

10.  Dendritic cells augment granulocyte-macrophage colony-stimulating factor (GM-CSF)/herpes simplex virus thymidine kinase-mediated gene therapy of lung cancer.

Authors:  P W Miller; S Sharma; M Stolina; K Chen; L Zhu; R W Paul; S M Dubinett
Journal:  Cancer Gene Ther       Date:  1998 Nov-Dec       Impact factor: 5.987

View more
  8 in total

1.  Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model.

Authors:  Russell K Pachynski; Alexander Scholz; Justin Monnier; Eugene C Butcher; Brian A Zabel
Journal:  J Vis Exp       Date:  2015-04-13       Impact factor: 1.355

2.  Central role of IFNgamma-indoleamine 2,3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity.

Authors:  Tao Gu; Rachael B Rowswell-Turner; Mehmet O Kilinc; Nejat K Egilmez
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

3.  Combination immune checkpoint blockade as an effective therapy for mesothelioma.

Authors:  Vanessa S Fear; Caitlin Tilsed; Jonathan Chee; Catherine A Forbes; Thomas Casey; Jessica N Solin; Sally M Lansley; William Joost Lesterhuis; Ian M Dick; Anna K Nowak; Bruce W Robinson; Richard A Lake; Scott A Fisher
Journal:  Oncoimmunology       Date:  2018-07-30       Impact factor: 8.110

4.  Cancer cells induce interleukin-22 production from memory CD4+ T cells via interleukin-1 to promote tumor growth.

Authors:  Cornelia Voigt; Peter May; Adrian Gottschlich; Anamarija Markota; Daniel Wenk; Inga Gerlach; Sebastian Voigt; Georgios T Stathopoulos; Kristina A M Arendt; Constanze Heise; Felicitas Rataj; Klaus-Peter Janssen; Melanie Königshoff; Hauke Winter; Isabelle Himsl; Wolfgang E Thasler; Max Schnurr; Simon Rothenfußer; Stefan Endres; Sebastian Kobold
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-17       Impact factor: 11.205

Review 5.  Serum amyloid A: an acute-phase protein involved in tumour pathogenesis.

Authors:  E Malle; S Sodin-Semrl; A Kovacevic
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

6.  PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective.

Authors:  M Lizeth Orozco Morales; Catherine A Rinaldi; Emma de Jong; Sally M Lansley; Joel P A Gummer; Bence Olasz; Shabarinath Nambiar; Danika E Hope; Thomas H Casey; Y C Gary Lee; Connull Leslie; Gareth Nealon; David M Shackleford; Andrew K Powell; Marina Grimaldi; Patrick Balaguer; Rachael M Zemek; Anthony Bosco; Matthew J Piggott; Alice Vrielink; Richard A Lake; W Joost Lesterhuis
Journal:  iScience       Date:  2021-12-04

7.  Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast-like stem cells and human osteosarcoma cell lines.

Authors:  Alenka Kovacevic; Astrid Hammer; Elke Stadelmeyer; Werner Windischhofer; Monika Sundl; Alpana Ray; Natascha Schweighofer; Gerald Friedl; Reinhard Windhager; Wolfgang Sattler; Ernst Malle
Journal:  J Cell Biochem       Date:  2008-02-15       Impact factor: 4.429

8.  Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used.

Authors:  Vanessa S Fear; Catherine A Forbes; Samuel A Neeve; Scott A Fisher; Jonathan Chee; Jason Waithman; Shao Kang Ma; Richard Lake; Anna K Nowak; Jenette Creaney; Matthew D Brown; Christobel Saunders; Bruce W S Robinson
Journal:  Cancer Immunol Immunother       Date:  2021-04-09       Impact factor: 6.968

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.